Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Revenue | — | 10,000 | — | — |
| Cost of revenue | — | 22,000 | — | — |
| Gross profit | — | −12,000 | — | — |
| Research and development | 2M | 4M | 7M | 7M |
| Selling, general and administrative | 4M | 4M | 4M | 5M |
| Operating income | −7M | −8M | −14M | −17M |
| Net income | −11M | −9M | −17M | −22M |
| Earnings per share | −0.01 | −0.02 | −0.07 | −0.11 |
| Earnings per share, diluted | −0.01 | −0.02 | −0.07 | −0.11 |
| Weighted average shares | 1.49B | 418M | 237M | 136M |
| Weighted average shares, diluted | 1.49B | 418M | 237M | 136M |
| Metric | 19/08/2026 | 18/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 3M | 1M | 4M | 6M | 19M |
| Short-term investments | — | — | 14,000 |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Operating cash flow | −7M | −8M | −13M | −15M |
| Depreciation and amortisation | 770,000 | 467,000 | 503,000 | 837,000 |
| Share-based compensation | 589,000 | 205,000 | 1M | 1M |
| Capital expenditure |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 102,000 |
| — |
| — |
| — |
| Current assets | — | — | 4M | 2M | 5M | — | — |
| Property, plant and equipment | — | — | 2M | 3M | 2M | — | — |
| Total assets | — | — | 5M | 8M | 11M | — | — |
| Current liabilities | — | — | 894,000 | 2M | 2M | — | — |
| Equity | — | — | 4M | 4M | 6M | 9M | 21M |
| Shares outstanding | — | — | 5.44B | 350M | 252M | — | — |
| Shares issued | — | — | 5.44B | 350M | 252M | — | — |
| 113,000 |
| 985,000 |
| 270,000 |
| 3M |
| Investing cash flow | −1M | −956,000 | −764,000 | −4M |
| Financing cash flow | 10M | 6M | 11M | 6M |